Hepatitis C virus infection: detection and treatment
Related Experiment Video
Updated: Aug 30, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Matthew L Rubinstein1, Mary E Miele
1Department of Pathology-Virology/Immunology, University Health System, San Antonio, TX, USA.
Insights
Hepatitis C virus (HCV) infection is a significant public health issue. This review covers HCV transmission, diagnosis, current treatments like interferon and ribavirin, and future therapeutic options.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Hepatitis C virus (HCV) is a blood-borne pathogen impacting millions, leading to severe liver conditions like cirrhosis and cancer.
- HCV infection represents a critical public health concern in the United States.
Purpose of the Study:
- To provide a comprehensive review of Hepatitis C virus infection.
- To discuss transmission, at-risk populations, and clinical manifestations of acute and chronic HCV.
- To detail diagnostic approaches and current/prospective treatment strategies.
Main Methods:
- Literature review of Hepatitis C virus transmission, risk groups, and clinical presentations.
- Description of diagnostic screening and confirmatory tests for HCV.
- Analysis of current combination therapy (interferon alpha-2b and ribavirin) and future treatments.
Main Results:
- HCV transmission routes and diverse risk groups are identified.
- Clinical presentations of acute and chronic HCV infection are outlined.
- Current treatment efficacy, side effects, and monitoring are discussed, alongside emerging therapies.
Conclusions:
- Effective diagnosis and management of Hepatitis C virus are crucial for public health.
- Combination therapy with interferon and ribavirin is a key treatment modality.
- Ongoing research into novel therapeutics promises improved outcomes for HCV patients.
Abstract:
Hepatitis C virus (HCV) is a blood-borne virus that infects the liver. HCV affects millions of Americans, and poses a serious public health threat with sequelae such as cirrhosis, hepatocellular carcinoma, and liver failure. This paper reviews means of transmission, characteristics of the various risk groups, and clinical presentations of both the acute and chronic stages of HCV infection. Diagnostic methods, including screening and confirmatory tests, along with relevant clinical and physiologic findings are also described. Additionally, treatment strategies, in particular combination therapy with interferon alpha-2b and ribavirin, are discussed. Contraindications, side effects, and monitoring of this therapeutic modality are considered. Finally, prospective treatments are presented.
More Related Videos
04:11Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
06:28Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction